1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lithuania Pharmaceuticals and Healthcare Report Q4 2016

Lithuania Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates


BMI View:

Lithuania's pharmaceutical and healthcare market represents a modest prospect for investment from multinational firms. A rising burden of chronic disease will translate into an increase in demand and sales; however, fiscal policies and the small size of the market will limit revenue earning opportunities. Headline Expenditure Projections

- Pharmaceuticals: EUR616mn (USD670mn) in 2015 to EUR633mn (USD697mn) in 2016; +2.9% in local currency terms and 4.0% in US dollar terms. Forecast unchanged from Q316.

- Healthcare: EUR2.45bn (USD2.67bn) in 2015 to EUR2.56bn (USD2.82bn) in 2016; 4.4% in local currency terms and 5.5% in US dollar terms. Forecast unchanged from Q316.

Table Of Contents

Lithuania Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Lithuania 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lithuania 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lithuania 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lithuania 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lithuania 2012-2020) 22
OTC Drug Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lithuania 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Lithuania 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Lithuania 2014-2020) 27
Industry Risk Reward Index 28
Central And Eastern Europe Risk/Reward Index - Q4 2016 28
Lithuania Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 40
Pricing Regime 40
Table: Wholesale Mark-Ups For Reimbursed And Non-Reimbursed Medicines 41
Reimbursement Regime 42
Table: Retail Mark-Ups For Reimbursed And Non-Reimbursed Medicines 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Lithuania 2010-2015) 47
Table: Healthcare Personnel (Lithuania 2010-2015) 47
Table: Healthcare Activity (Lithuania 2010-2015) 48
Research and Development 49
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research-Based Industry 55
Table: Members of the Innovative Pharmaceutical Industry Association (IFPA) 55
Table: Multinational Market Activity 56
Generic Drugmakers 56
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 58
Company Profile 60
Valentis 60
Sanitas (Valeant) 62
Sicor Biotech (Teva) 65
Demographic Forecast 68
Table: Population Headline Indicators (Lithuania 1990-2025) 69
Table: Key Population Ratios (Lithuania 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Lithuania 1990-2025) 70
Table: Population By Age Group (Lithuania 1990-2025) 70
Table: Population By Age Group % (Lithuania 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.